中国寄生虫学与寄生虫病杂志 ›› 1991, Vol. 9 ›› Issue (2): 140-142.

• • 上一篇    下一篇

阿苯达唑治疗肝泡球蚴病80例临床观察

李明,李维新,刘雄洲,李维军,黄光财,张国才,王启华,王西林,李世耀,李明祖,杨春生   

  1. 宁夏西吉县人民医院; 宁夏回族自治区畜牧局; 宁夏西吉县人民医院; 宁夏固原地区医院; 宁夏西吉县兽医站; 宁夏回族自治区畜牧局; 宁夏西吉县人民医院; 宁夏西吉县人民医院; 宁夏西吉县人民医院; 宁夏西吉县人民医院; 宁夏回族自治区畜牧局
  • 收稿日期:2017-01-09 修回日期:2017-01-09 出版日期:1991-05-31 发布日期:2017-01-09

EIGHTY CASES OF ALVEOLAR HYDATID DISEASE TREATED WITH ALBEISDAZOLE

  • Received:2017-01-09 Revised:2017-01-09 Online:1991-05-31 Published:2017-01-09

摘要: 从1985年起,用口服阿苯达唑治疗泡球蚴病80例均获显著近期疗效。甲组72例,口服8-10mg/kg·d×30,间隔10d,再服另一疗程,连服3-12个月;乙组8例,15.6—20mg/kg·d×14,每疗程间隔10d,连服3—6个月。经3—5年随访,一般症状均有好转,体重增加2—9.5kg,占77.8(45/58)能自理生活或参加轻体力劳动。服药2—3个月黄疸消失,黄疸指数恢复正常的占80%(20/25);肝功有明显改善的占73%(48/66);絮浊度化验约50%转为正常;复查原来肿大的肝脏:剑突下缩小1-6cm占50%(40例),右肋缘下缩小1—3cm占42.5%(34例),左肋缘下缩小占

关键词: 阿苯达唑, 肝泡球蚴病, 治疗

Abstract: Alveolar hydatid disease occurs frequently in Xiji County of Ningxia. 80 cases of the disease were treated orally with albendazole from 1985 to 1988 and the short-term results proved satisfactory.The treatment consisted of two groups. Group Ⅰ included 72 cases which were orally given 8-10 mg/kg · d of albendazole 2 to 3 times a day after each meal for 30 days and then stop taking the medicine for 10 days as one trealment course. The treatment continued 3-12 months comprising about 24 courses were given with the highest dosage of 412g. Group Ⅱ included 8 cases who were given 15.6-20mg/kg · d of the medicine for 14 days (one course) and every two weeks with a 10 days interval. The treatment of group Ⅱ continued 3-6 months which totalled 19-24 courses with the highest dosage of 270g. All the treated patients tolerate well except that a few of them felt giddy and had diarrhoea which disappeared after the withdrawal of medicine.Through 3-5 years, follow-up observation, it was found that the gener alsymptoms of the treated partients improved and their body weight increased by 2-9.5kg., some of them could take part in light physical labour. The jaundice index in 80% of them returned to normal. SGPT in 86.4% decreased to within normal range. The enlarged livers in half of the patients decreased by 1-6cm. 23.7% of the patients were reexamined by B ultrasound scanning which revealed that their enlarged liver reduced in size while the liquifaction area and the shadows of calcification in the livers in 42.5% patients increased obviously.